Home › Markets › Health Care › ALDX

Aldeyra Therapeutics Inc. (ALDX)

ALDX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.8998
-0.66% on the day
Market cap
$54.3M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerALDX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2014
SEC CIK0001341235
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52024-08-01
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-08-06
Latest current report8-K2026-09-29
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 646 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
TLPHTalphera Inc.$1.07-0.93%$55.5M
BOLDBoundless Bio Inc.$2.43-4.71%$56.2M
RNXTRenovoRx Inc.$1.15-8.00%$51.9M
ATHEAlterity Therapeutics Limited$2.85-2.73%$51.9M
HYPDHyperion DeFi Inc.$3.36-3.17%$51.9M
MREOMereo BioPharma Group plc$0.3200+1.52%$51.1M
CNTBConnect Biopharma Holdings Limited$0.9188+1.45%$57.9M
IBIOiBio Inc.$0.7818-13.44%$50.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier